BioCapital Europe 2023

Richard Hausmann, CEO of Combinostics, will discuss our company history and development of the cNeuro® suite, our complete AI software solution that supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring. The platform includes the cMRI™ and cDSI™ applications, pending cPET™ application (WIP), industry-first Dementia Differential Analysis report, and clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy. 

BioCapital Europe 2023

March 9, 2023
Presentation at 4:20 pm CET

Richard Hausmann,
CEO of Combinostics

Recent News & Events

AAIC 2023

Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.

Read More »